Study to evaluate the feasibility of universal HIV testing and ART regardless of CD4 count using the Test and Treat strategy among MSM and transgender women
Status:Ongoing
Phase:Other
Principal Investigator(s):
Objective:Acceptance of regular HIV testing among HIV-negative MSM/TG and of immeduate ART regardless of CD4 count among newly diagnosed HIV-positive MSM/TG.
Prevention Option(s):Treatment U=U
Study Design:Randomized
Trial Sponsors:
Department of Disease Control at the Ministry of Public Health, Government Pharmaceutical Organization, National Research Council, National Security Office, TREAT Asia, WHO and AIDS fund
Start Date
End Date
January 31, 2012
December 31, 2015
Enrollment:0
Age range:
↔
any
Population:Gay and Bisexual Men Who Have Sex with Men, People Living with HIV